is glp-1 a hoax New weight-loss scams fueled by hype As interest in GLP-1 medication

That raises the question of whether and how GLP-1R agonists, which were initially developed for use in the rest of the body, make their way into the brain

Novo Nordisk plans to present the findings at the Clinical Trials in Alzheimers Disease (CTAD) conference next week and the full datasets at the AD/PD Alzheimers and Parkinsons Diseases Conference in March 2026

Global GLP-1 Autoinjector and Pen Injector Market is estimated to witness a rapid growth with at a 15.6% CAGR during the forecast period for 2026 to 2035

Disclaimer Nothing in this article is meant to be misconstrued as medical advice

Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus

doi:10.1007/s10753-018-00954-3 99